Here are the key details to know:
1. The Ellipsys System is a minimally invasive, single catheter-based system for end-stage renal disease patients.
2. The SKI Vascular Center participated in the U.S. pivotal trial for Ellipsys for FDA approval.
3. The team at SKI Vascular Center have treated over 40 patients with the technology leading up to FDA approval.
More articles on turnarounds:
11 healthcare fraud, lawsuit stories of 2018: ASCs, surgeons & more
ORHub’s Surgical Spotlight system offers AI insights to ASCs, hospitals — 3 insights
Despite increased demand for imaging services, high costs leave providers scrambling — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.